Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from Moderna

2 Vaccine Stocks to Buy on the Dip

Given the cutting-edge pipeline for these two vaccine companies, double-digit slumps in these stocks present a compelling entry point for investors.

Stocks Settle Sharply Lower on the Outlook for Slower Fed Rate Cuts

Stocks Settle Sharply Lower on the Outlook for Slower Fed Rate Cuts

The S&P 500 Index ($SPX ) (SPY ) Friday closed down -1.32%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed down -0.70%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed down -2.40%. Stocks retreated Friday, with the S&P 500 and Nasdaq 100 falling to 1-1/2 week...

Stocks Tumble as Hawkish Fed and Strong US Economic News Boosts Bond Yields

Stocks Tumble as Hawkish Fed and Strong US Economic News Boosts Bond Yields

The S&P 500 Index ($SPX ) (SPY ) today is down -1.17%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is down -0.72%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is down -2.03%. Stocks today extended Thursday’s decline, with the S&P 500 and the Dow Jones Industrials...

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Pfizer, Moderna, BioNTech Take A Beating After Trump Taps Kennedy To Head Up HHS

Pfizer stock and other vaccine shares tumbled Friday morning after Trump picked Kennedy to lead the Department of Health and Human Services.

Investors Business Daily

Pharma shares hit as Trump picks RFK Jr to lead health department

Choice of vaccine critic knocks some of world’s biggest drugmakers including Moderna, AstraZeneca and GSK

The Guardian - UK

Moderna Stock Outlook: Is Wall Street Bullish or Bearish?

Moderna has underperformed the broader market and its peers over the past year, and Wall Street analysts are cautious about the stock’s prospects.

Don't wait for a holiday surge. Now is a good time to get your flu and COVID-19 vaccines

Health officials say it's important to get flu and COVID-19 vaccines ahead of the holidays when respiratory bugs tend to spread

The Independent UK

inkl

Read news from The Economist, FT, and more,
with one subscription

Moderna Slashes Hefty Premarket Gain With A Beat That's 'Not A Beat'

Moderna Slashes Hefty Premarket Gain With A Beat That's 'Not A Beat'

Moderna crushed third-quarter expectations on Thursday and turned around a surprise profit. But Moderna stock pulled back.

Investors Business Daily

Option Volatility And Earnings Report For November 4 - 8

Option Volatility And Earnings Report For November 4 - 8

We have some important companies with Palantir, Super Micro computer, Block, Moderna, Qualcomm, Arista Networks, Gilead Sciences and Airbnb all set to report.

Older adults should get 2 doses of the updated COVID shot, CDC says

Older adults should get 2 doses of the updated COVID shot, CDC says

The 2024-2025 COVID-19 vaccines are available, and the CDC recommends that certain groups get two doses, spaced six months apart.

Norovirus vaccine: How does the trial work, when could it be available and what will it mean for the NHS?

Norovirus vaccine: How does the trial work, when could it be available and what will it mean for the NHS?

Could the new ‘winter vomiting bug’ vaccine save the NHS in future winters?

The Independent UK

Doctors trial world’s first mRNA vaccine against vomiting bug norovirus

Doctors trial world’s first mRNA vaccine against vomiting bug norovirus

Jab could bring huge health and economic benefits as virus often spreads very rapidly and can be serious

The Guardian - UK

World-first vaccine for vomiting bug norovirus trialled in the UK

World-first vaccine for vomiting bug norovirus trialled in the UK

The jab uses mRNA technology to tell the immune system to recognise a ‘foreign’ protein on viruses and mount an attack.

The Independent UK

World’s first vaccine for winter vomiting bug norovirus to be trialled in UK

World’s first vaccine for winter vomiting bug norovirus to be trialled in UK

Final phase of vaccine trial to start soon using the same technology as Covid-19 jabs

The Independent UK

Get all your
news in one place.

100’s of premium titles.
One news app.

Earnings Preview: What to Expect From Moderna's Report

Moderna is all set to release its fiscal third-quarter earnings next month, and analysts project its loss to rise in double digits.

Investors Business Daily

Nvidia's 84% Expected Profit Growth Looms Large In S&P 500

Nvidia is expected to boost the S&P 500 Q3 earnings growth rate. Meta Platforms and Alphabet may lift Communications Services earnings.

The Conversation

One of science’s greatest achievements: how the rapid development of COVID vaccines prepares us for future pandemics

Since COVID was first reported in December 2019, there have been more than 775 million recorded infections and more than 7 million deaths from the disease. This makes COVID the seventh-deadliest pandemic in recorded history.

Investors Business Daily

Missed Nvidia? 10 Other S&P 500 Stocks Will Make You Much Richer

It's hard not to love Nvidia — given its huge run this year. But analysts think you can do much better with other S&P 500 stocks.

Get all your
news in one place.

100’s of premium titles.
One news app.

The Independent UK

It's time to roll up sleeves for new COVID, flu shots

Fall means it’s time for just about everybody to get up to date on their flu and COVID-19 vaccines

Will the XEC COVID subvariant bring a fall wave of infections? What to know about symptoms and spread

The U.S. is coming down from its biggest COVID summer surge yet as a new subvariant emerges—but new vaccines are here, too.

Midday stock movers: Adobe, Boeing, Moderna

Here are the stocks making the biggest market moves.

Investors Business Daily

Moderna's Pain Continues Amid Flurry Of Downgrades Following 'Tough' R&D Day

Moderna stock tumbled again Friday on a series of downgrades and price-target cuts following a "tough update" at its R&D Day.

The Independent UK

Cancer vaccine breakthrough as tests show positive results on patients with tumours

The jab, known as mRNA-4359, is developed by Moderna

Stock Market Today: Stocks Rise in Choppy Day for Markets

Moderna was the worst S&P 500 stock today after the vaccine maker slashed its R&D budget.

Midday stock movers: Kroger, Alaska Air, Moderna

Here are the stocks making the biggest market moves.

1 2 3 4 5

People

Robert F. Kennedy Jr

Demetre Daskalakis

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Organisations

US Federal Reserve

inkl

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

236,948 stories

100,195 stories

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.

Download on the AppStore

Get it on Google Play